Sivan Cohen

Sivan Cohen is a Senior Principal Scientist at Genentech, specializing in immunology and cancer biology with 16 years of experience in basic and translational research. They manage a team of three senior scientific researchers and lead the immunogenicity prediction strategy for Genentech’s biotherapeutics portfolio. Sivan has a strong publication record, with over 25 articles in top-tier journals, and has supported 28 biotherapeutics throughout various development stages at Genentech. They completed their Ph.D. in Immunology at the Weizmann Institute of Science and have held positions at both the Weizmann Institute and Duke University, where they contributed significant insights into immune responses and cell metabolism.